Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP1/AS02A Malaria Vaccine Phase IIb in Children
NCT00223990Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Apr 2005
- Primary completion
- Apr 2006
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of FMP1/AS02A in Plasmodium falciparum malaria, sponsored by U.S. Army Medical Research and Development Command. Started Apr 2005; status: completed.
02
Drugs
FMP1/AS02A
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00223990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223990.